✦ LIBER ✦

P308 Optimal duration of neoadjuvant exemestane treatment in elderly women with estrogen receptor-positive/HER2-negative breast cancer

✍ Scribed by H. Takei; T. Saito; Y. Ishikawa; Y. Hayashi; M. Kurosumi; T. Kai; T. Tabei

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Optimal treatment strategies in postmeno

✍ Joseph Gligorov; Jean-Pierre Lotz 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 323 KB

Safety and Efficacy of Everolimus With E

✍ Pritchard, Kathleen I.; Burris, Howard A.; Ito, Yoshinori; Rugo, Hope S.; Dakhil 📂 Article 📅 2013 🏛 CIG Media Group, LP. 🌐 English ⚖ 782 KB

Efficacy of everolimus with exemestane v

✍ Noguchi, Shinzaburo; Masuda, Norikazu; Iwata, Hiroji; Mukai, Hirofumi; Horiguchi 📂 Article 📅 2013 🏛 Springer Japan 🌐 English ⚖ 662 KB

NICE guidance on everolimus in combinati

✍ Burke, Martyn J; Garrett, Zoe; George, Elisabeth; Adler, Amanda I 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 53 KB

BOLERO-2: Everolimus in combination with

✍ Mario Campone; Martine Piccart; Kathleen I. Pritchard; Cindy Xu; Michael Gnant; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Everolimus in Combination with Exemestan

✍ Sohita Dhillon 📂 Article 📅 2013 🏛 Springer International Publishing AG 🌐 English ⚖ 426 KB